Ouest-France highlights Peters Surgical’s new project: to develop in France a biosourced surgical glue, essential for surgeons. This green innovation will be accompanied by the creation of about ten new jobs.

Peters Surgical, a French mid-size Medtech founded in 1926, announces the development of a bio-sourced haemostatic surgical glue in Domalain, with new opening jobs at its Breton site.

Peters Surgical was able to benefit from Innov’up program funding for research on a bio-sourced haemostatic glue.

As part of the 8th Edition of the “Rencontres du Progrès Médical” organized by SNITEM, Thierry Herbreteau, CEO of Peters Surgical was able to speak during the session.

Thierry Herbreteau explains the impacts of the #Covid19 crisis on Peters Surgical’s business during the 1st wave and the pillars on which the company wishes to work to relaunch its activity.